Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial

Published:2023-02-21 Issue:2 Volume:37 Page:259-269
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Li Huiping,Huang Yan,Chen Zhendong,Zeng Aiping,Zhang Helong,Yu Yan,Wei Shihong,Li Qingshan,Wang Xiaojia,Wang Xiangcai,Wang Xiuwen,Yang Runxiang,Dai Xiumei,Bi Minghong,Sun Tao,Zhang Qingyuan,Han Cuicui,Li Yujie,Kang Xiaoyan,Liu Yaxin,Zhang Li

Funder

Qilu Pharmaceutical Co., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s40259-023-00579-5.pdf

Reference32 articles.

1. Huang J, Gu T, Ying J. A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer. Int J Clin Oncol. 2017;22(6):1015–25. https://doi.org/10.1007/s10147-017-1159-1.

2. Oster G, Lamerato L, Glass AG, et al. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer. 2013;21(12):3279–86. https://doi.org/10.1007/s00520-013-1887-3.

3. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243–9.

4. Casimiro S, Vilhais G, Gomes I, Costa L. The roadmap of RANKL/RANK pathway in cancer. Cells. 2021;10(8):1978. https://doi.org/10.3390/cells10081978.

5. Menshawy A, Mattar O, Abdulkarim A, et al. Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials. Support Care Cancer. 2018;26(4):1029–38. https://doi.org/10.1007/s00520-018-4060-1.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments;International Journal of Molecular Sciences;2024-07-26

2. Comparison of the efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: a subgroup analysis of a randomized, double-blinded phase III study;2024-06-11

3. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28